References
- Amin F., Davidson M., Davis K. L. Homovanillic acid measurement in clinical research: a review of methodology. Schizophrenia Bulletin 1992; 18: 123–141
- Berger P. A., Faull K. F., Kilkowski J., Anderson P. J., Kraemer H., Davis K. J., Barchas J. D. CSF monoamine metabolites in depression and schizophrenia. American Journal of Psychiatry 1980; 137: 174–180
- Bowers M. B. Central dopamine turnover in schizophrenic syndromes. Archives of General Psychiatry 1974; 31: 50–54
- Bowers M. B., Study R. E. Cerebrospinal fluid cyclic AMP and acid monoamine metabolites following probenecid: studies in psychiatric patients. Psychopharmacology 1979; 62: 7–22
- Bowers M. B., Van Woert M. H. 6-hydroxydopamine, noradrenergic reward and schizophrenia. Science 1972; 175: 920–921
- Chase T. N., Schnur J. A., Gordon E. K. Cerebrospinal fluid monamine catabolites in drug-induced extrapyramidal disorders. Neuropharmacology 1970; 9: 265–268
- Cox D. R., Hinkley D. V. Theoretical Statistics. Chapman and Hall, London 1974
- Davidson M., Davis K. L. A comparison of plasma homovanillic acid concentrations in schizophrenic patients and normal controls. Archives of General Psychiatry 1988; 45: 561–563
- Davis K. L., Davidson M., Mohs R.C, Kendler K. S., Davis B. M., Johns C. A., DeNigris Y., Horvath T. B. Plasma homovanillic acid concentration and the severity of schizophrenic illness. Science 1985; 227: 1601–1602
- Gerner R. H., Fairbanks L., Anderson G. M., Young J. G., Scheinin M., Linnoila M., Cohen D. J., Hare T. A., Schaywitz B. A. CSF neurochemistry in depressed manic and schizophrenic patients, compared with that of normal controls. American Journal of Psychiatry 1984; 141: 1533–1540
- Gottfries C. G., Gottfries I., Johansson B., Olson R., Persson T., Roos B.-E., Sjostrom R. Acid monoamine metabolites in human cerebrospinal fluid and their relations to age and sex. Neuropharmacology 1971; 10: 665–672
- Hedges L. V., Olkin I. Statistical Methods for Meta-Analysis. Academic Press, New York 1990
- Heritch A. J. Evidence for reduced and dysregulated turnover of dopamine in Schizophrenia. Schizophrenia Bulletin 1985; 16: 605–615
- Karoum F., Karson C. N., Bigelow L. B., Lawson W. B., Wyatt R. J. Preliminary evidence of reduced combined output of dopamine and its metabolites in chronic schizophrenia. Archives of General Psychiatry 1987; 44: 604–607
- Kirstein L., Bowers M. B., Heninger G. CSF amine metabolites, clinical symptoms and body movement in psychiatric patients. Biological Psychiatry 1976; 11: 421–434
- Lindstrom L. H. Low HVA and normal 5-H1AA CSF levels in drug-free schizophrenic patients compared to healthy volunteers: correlations to symptomatology and family history. Psychiatry Research 1985; 14: 265–273
- MacKay A. V. P. Positive and negative schizophrenic symptoms and the role of dopamine. British Journal of Psychiatry 1980; 137: 379–383
- Nyback H., Berggen B. M., Hindmarsh T., Sedvall G., Wiesel F. A. Cerebroventricular size and cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy volunteers. Psychiatry Research 1983; 9: 301–308
- Persson T., Roos B.-E. Acid metabolites from monoamine in cerebrospinal fluid of chronic schizophrenics. British Journal of Psychiatry 1969; 115: 95–98
- Post R. M., Fink E., Carpenter W. T., Goodwin F. K. Cerebrospinal fluid amine metabolites in acute schizophrenia. Archives of General Psychiatry 1975; 32: 1063–1069
- Rimon R., Roos B. E., Rakkolainen V., Alanen Y. The content of 5-HIAA and HVA in the CSF of patients with acute schizophrenia. Journal of Psychsomatic Research 1971; 15: 375–378
- Sedvall G., Fyro B., Nyback H., Wiesel F., Wode-Helodt B. Mass fragmentometric determination of homovanillic acid in lumbar cerebrospinal fluid of schizophrenic patients during treatment with antipsychotic drugs. Journal of Psychiatric Research 1974; 11: 75–80
- Van Kammen D. P., Mann L. S., Sternberg D. E., Scheinin M., Ninan P. T., Marder S. R., Van Kammen W. B., Rieder R. O., Linoila M. Dopamines-hydroxylase activity and homovanillic acid in spinal fluid of patients with brain atrophy. Science 1983; 220: 974–977
- Van Kammen D. P., Van Kammen W. B., Mann L. S., Seppala T., Linoila M. Dopamine metabolism in the cerebrospinal fluid of drug-free schizophrenic patients with and without cortical atrophy. Archives of General Psychiatry 1986; 43: 978–983
- Van Praag H. M. The significance of dopamine for the mode of action of neuroleptics and the pathogenesis of schizophrenia. British Journal of Psychiatry 1977; 130: 463–474